THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
Patent Owner
Stats
- 568 US PATENTS IN FORCE
- 109 US APPLICATIONS PENDING
- Mar 13, 2018 most recent publication
Details
- 568 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 35,484 Total Citation Count
- Aug 18, 1982 Earliest Filing
- 689 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0051,083 BI-SPECIFIC ANTIBODIES AGAINST TIM-3 AND PD-1 FOR IMMUNOTHERAPY IN CHRONIC IMMUNE CONDITIONSNov 03, 17Feb 22, 18[A61K, C07K]
2018/0021,455 RECEPTOR-TARGETED NANOPARTICLES FOR ENHANCED TRANSCYTOSIS MEDIATED DRUG DELIVERYAug 31, 17Jan 25, 18[A61K, C07K]
2018/0000,066 Platelet Protection Solution Having Beta-Galactosidase and Sialidase InhibitorsSep 13, 17Jan 04, 18[A01N]
2017/0349,950 T CELL BALANCE GENE EXPRESSION, COMPOSITIONS OF MATTERS AND METHODS OF USE THEREOFAug 25, 17Dec 07, 17[C12Q, G01N]
2017/0333,348 MASS PRODUCTION AND SIZE CONTROL OF NANOPARTICLES THROUGH CONTROLLED MICROVORTICESJun 08, 17Nov 23, 17[A61K]
2017/0334,977 Targeting Apolipoprotein E (APOE) in Neurologic DiseaseOct 20, 15Nov 23, 17[C12N, C07K]
2017/0327,578 ANTI-CEACAM1 RECOMBINANT ANTIBODIES FOR CANCER THERAPYDec 20, 16Nov 16, 17[A61K, C07K]
2017/0319,500 SELF-ASSEMBLED GELS FOR CONTROLLED DELIVERY OF BIOLOGICS AND LABILE AGENTSMay 08, 17Nov 09, 17[A61K, A61M]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0342,109 Natural IGM Antibodies and Inhibitors ThereofAbandonedMay 08, 17Nov 30, 17[A61K, C07K]
2017/0000,899 RECEPTOR-TARGETED NANOPARTICLES FOR ENHANCED TRANSCYTOSIS MEDIATED DRUG DELIVERYAbandonedNov 25, 14Jan 05, 17[A61K, C07K]
2016/0274,043 Enhanced 13C NMR by Thermal Mixing with Hyperpolarized 129XEAbandonedMar 17, 16Sep 22, 16[G01N]
2016/0237,430 ALLELE-SPECIFIC RNA SILENCING FOR THE TREATMENT OF HYPERTROPHIC CARDIOMYOPATHYAbandonedSep 23, 14Aug 18, 16[C12N]
2016/0228,550 COMPOSITIONS AND METHODS OF PROPHYLAXIS FOR CONTACT DERMATITISAbandonedApr 14, 16Aug 11, 16[A61K]
2016/0129,030 TREATMENT OF MTOR HYPERACTIVE RELATED DISEASES AND DISORDERSAbandonedJun 11, 14May 12, 16[A61K, G01N, A61N]
2016/0115,549 Diagnosing and Monitoring CNS Malignancies Using MicroRNAAbandonedOct 05, 15Apr 28, 16[A61K, C12Q]
2016/0031,874 SUBSTITUTED AMINOTHIAZOLES FOR THE TREATMENT OF TUBERCULOSISAbandonedMar 13, 14Feb 04, 16[C07D]
2016/0022,727 IMMUNOMODULATING COMPOUNDS AND RELATED COMPOSITIONS AND METHODSAbandonedFeb 25, 15Jan 28, 16[A61K]
2015/0362,497 Autoantibody Signature for the Early Detection of Ovarian CancerAbandonedJan 30, 14Dec 17, 15[G01N]
2015/0355,185 USING GALECTIN-BINDING CARBOHYDRATES AS PREDICTORS OF MELANOMA PROGRESSION AND METASTASISAbandonedJan 16, 14Dec 10, 15[G01N]
2015/0346,100 METABOLIC IMAGING METHODS FOR ASSESSMENT OF OOCYTES AND EMBRYOSAbandonedJan 07, 14Dec 03, 15[G01N]
2015/0343,023 METHODS FOR CARDIOPROTECTION AND CARDIOREGENERATION WITH DIMERS OF EGF FAMILY LIGANDSAbandonedMay 11, 15Dec 03, 15[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.